Leena Ahmed
Research Assistant
At ExEd, Leena works closely with scientists to express and characterize recombinant proteins, playing a key role in both technology development and therapeutic discovery. Her work focuses on producing proteins using mammalian cell expression systems and running standardized assays to tackle 'difficult-to-express’ therapeutics.
Bio
Leena completed her undergraduate degree at the University of Exeter, which included a professional training year focused on developing a drug screening approach for idiopathic pulmonary fibrosis (IPF). In her final year, Leena's dissertation project involved establishing a new animal model to study type 1 diabetes, earning her the Final Year Society of Endocrinology Prize for achieving the highest grade in the field.
After graduating, Leena joined Agenus, an immuno-oncology antibody therapeutics company, where she contributed to drug discovery projects by expressing various antibodies and other proteins and performing analytical assays. She also identified areas for improvement in protein production, optimizing and enhancing the process at both multi-litre scales and in high-throughput systems.
At ExEd, Leena works closely with scientists to express and characterize recombinant proteins, playing a key role in both technology development and therapeutic discovery. Her work focuses on producing proteins using mammalian cell expression systems and running standardized assays to tackle 'difficult-to-express’ therapeutics.
Bio
Leena completed her undergraduate degree at the University of Exeter, which included a professional training year focused on developing a drug screening approach for idiopathic pulmonary fibrosis (IPF). In her final year, Leena's dissertation project involved establishing a new animal model to study type 1 diabetes, earning her the Final Year Society of Endocrinology Prize for achieving the highest grade in the field.
After graduating, Leena joined Agenus, an immuno-oncology antibody therapeutics company, where she contributed to drug discovery projects by expressing various antibodies and other proteins and performing analytical assays. She also identified areas for improvement in protein production, optimizing and enhancing the process at both multi-litre scales and in high-throughput systems.
At ExEd, Leena works closely with scientists to express and characterize recombinant proteins, playing a key role in both technology development and therapeutic discovery. Her work focuses on producing proteins using mammalian cell expression systems and running standardized assays to tackle 'difficult-to-express’ therapeutics.
Bio
Leena completed her undergraduate degree at the University of Exeter, which included a professional training year focused on developing a drug screening approach for idiopathic pulmonary fibrosis (IPF). In her final year, Leena's dissertation project involved establishing a new animal model to study type 1 diabetes, earning her the Final Year Society of Endocrinology Prize for achieving the highest grade in the field.
After graduating, Leena joined Agenus, an immuno-oncology antibody therapeutics company, where she contributed to drug discovery projects by expressing various antibodies and other proteins and performing analytical assays. She also identified areas for improvement in protein production, optimizing and enhancing the process at both multi-litre scales and in high-throughput systems.
→